Edgestream Partners L.P. Has $1.60 Million Stake in Balchem Co. (NASDAQ:BCPC)

Edgestream Partners L.P. reduced its holdings in Balchem Co. (NASDAQ:BCPC) by 47.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 9,109 shares of the basic materials company’s stock after selling 8,139 shares during the quarter. Edgestream Partners L.P.’s holdings in Balchem were worth $1,603,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in BCPC. Envestnet Portfolio Solutions Inc. grew its holdings in Balchem by 1.5% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 3,926 shares of the basic materials company’s stock valued at $604,000 after buying an additional 59 shares during the last quarter. Inspire Investing LLC boosted its position in shares of Balchem by 2.7% in the third quarter. Inspire Investing LLC now owns 2,348 shares of the basic materials company’s stock valued at $413,000 after acquiring an additional 62 shares during the period. Hsbc Holdings PLC grew its stake in shares of Balchem by 1.5% in the second quarter. Hsbc Holdings PLC now owns 4,915 shares of the basic materials company’s stock worth $757,000 after acquiring an additional 75 shares during the last quarter. Atomi Financial Group Inc. increased its position in Balchem by 6.1% during the third quarter. Atomi Financial Group Inc. now owns 1,674 shares of the basic materials company’s stock worth $295,000 after acquiring an additional 96 shares during the period. Finally, Xponance Inc. raised its stake in Balchem by 5.2% during the 2nd quarter. Xponance Inc. now owns 2,046 shares of the basic materials company’s stock valued at $315,000 after purchasing an additional 102 shares during the last quarter. 87.91% of the stock is currently owned by institutional investors.

Balchem Stock Performance

Shares of NASDAQ BCPC opened at $177.99 on Wednesday. The firm has a market capitalization of $5.79 billion, a price-to-earnings ratio of 47.85, a PEG ratio of 5.41 and a beta of 0.67. Balchem Co. has a one year low of $124.34 and a one year high of $186.03. The business has a fifty day simple moving average of $174.61 and a 200 day simple moving average of $167.93. The company has a current ratio of 2.98, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21.

Analyst Upgrades and Downgrades

Several analysts have issued reports on BCPC shares. HC Wainwright raised their price target on shares of Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a research report on Monday, October 28th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.